| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 13, 2006
From the Stroke Research Group (L.C.J., J.E., R.L.F., M.M.B.), UCL Institute of Neurology, University College London; the Department of Neurology, the Adelaide and Meath Hospital, Dublin (D.J.H.M.); the National Children’s Hospital, Trinity College Dublin, Ireland (D.J.H.M.); and the Department of Neuroradiology (A.C.), St. George’s Hospital, London, England. * To whom correspondence should be addressed. E-mail: m.brown{at}ion.ucl.ac.uk.
Background and Purpose--The long-term outcome of endovascular intervention compared with best medical management of patients with symptomatic vertebral artery stenosis is uncertain. We therefore compared these treatments in a randomized trial with long-term follow-up. Methods--In the international, multicenter Carotid And Vertebral Artery Transluminal Angioplasty Study, 16 patients with symptomatic vertebral artery stenosis were randomized in equal proportions to receive endovascular therapy (balloon angioplasty or stenting) or best medical treatment alone. An independent neurologist followed up the patients for as long as 8 years. Results--Endovascular intervention was technically successful in all 8 patients, but 2 patients experienced transient ischemic attack at the time of endovascular treatment. There were no deaths or strokes in any arterial territory within the first 30 days. During a mean follow-up period of 4.7 years, no patient in either treatment group experienced a vertebrobasilar territory stroke, but 3 patients in each treatment arm died of myocardial infarction or carotid territory stroke, and 1 endovascular patient had a nonfatal carotid territory stroke. Conclusions--Patients with vertebral artery stenosis were more likely to have carotid territory stroke and myocardial infarction during follow-up than have recurrent vertebrobasilar stroke. The trial failed to show a benefit of endovascular treatment of vertebral artery stenosis, but the numbers of patients included was small. Larger randomized trials are required to determine whether vertebral artery stenting is justified in patients at higher risk of vertebrobasilar stroke. Treatment of patients with vertebral artery stenosis should focus on global reduction of vascular risk, including prevention of carotid territory stroke and myocardial infarction.
Revised on November 28, 2006
Accepted on December 5, 2006
Long-Term Outcome After Angioplasty and Stenting for Symptomatic Vertebral Artery Stenosis Compared With Medical Treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS). A Randomized Trial
Lucy J. Coward MRCP;
This article has been cited by other articles:
![]() |
G. Gulli, S. Khan, and H. S. Markus Vertebrobasilar Stenosis Predicts High Early Recurrent Stroke Risk in Posterior Circulation Stroke and TIA Stroke, August 1, 2009; 40(8): 2732 - 2737. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Marquardt, W. Kuker, A. Chandratheva, O. Geraghty, and P. M. Rothwell Incidence and prognosis of >=50% symptomatic vertebral or basilar artery stenosis: prospective population-based study Brain, April 1, 2009; 132(4): 982 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. H. Yu, T. W. H. Leung, J. S. Y. Lam, W. W. M. Lam, and L. K. S. Wong Symptomatic Ostial Vertebral Artery Stenosis: Treatment with Drug-eluting Stents--Clinical and Angiographic Results at 1-year Follow-up Radiology, April 1, 2009; 251(1): 224 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mazighi, J. Labreuche, F. Gongora-Rivera, C. Duyckaerts, J.-J. Hauw, and P. Amarenco Autopsy Prevalence of Proximal Extracranial Atherosclerosis in Patients With Fatal Stroke Stroke, March 1, 2009; 40(3): 713 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Jansen, J. Fiehler, M. Hartmann, and H. Bruckmann Protection or Nonprotection in Carotid Stent Angioplasty: The Influence of Interventional Techniques on Outcome Data From the SPACE Trial Stroke, March 1, 2009; 40(3): 841 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. I. Mejia, S. Park, M. Ning, and F. S. Buonanno Pearls and Oy-sters: Reversible iatrogenic Balint syndrome Neurology, June 10, 2008; 70(24): e97 - e98. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |